Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis

Nafisa Kuwajerwala, Eugenia Cifuentes, Subhash Gautam, Mani Menon, Evelyn R. Barrack and G. Prem Veer Reddy
Nafisa Kuwajerwala
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugenia Cifuentes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subhash Gautam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mani Menon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evelyn R. Barrack
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Prem Veer Reddy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Effect of 1-h and 24-h resveratrol treatment on [3H]thymidine incorporation into DNA of LNCaP cells. Exponentially growing cells were treated with various concentrations of resveratrol for either 1 h (▪) or 24 h (•) as described in “Materials and Methods.” They were then pulse-labeled with [3H]thymidine for 30 min, and radioactivity incorporated into DNA was measured.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effect of resveratrol on [3H]thymidine and [5-3H]uridine incorporation into LNCaP cells. Cells treated with resveratrol were pulse-labeled with [3H]thymidine (•) or [5-3H]uridine (▪) and were processed for measuring radioactivity incorporated into nucleic acids as described in “Materials and Methods.”

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Comparison of resveratrol effect on [3H]thymidine incorporation in androgen-sensitive (LNCaP), androgen-independent (DU145) prostate epithelial cells, and NIH 3T3 fibroblast cells. LNCaP (•) and DU145 (▪) prostate epithelial cells, and NIH 3T3 fibroblast cells (▴) were plated similarly and treated with resveratrol for 24 h, and [3H]thymidine incorporation into DNA was measured as described in “Materials and Methods.”

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Cell cycle analysis of exponentially growing LNCaP cells treated with resveratrol. Exponentially growing LNCaP cells were treated with diluent (control) or with 10 μm or 20 μm resveratrol as described in “Materials and Methods.” After 24 h, the cells were prepared for flow cytometry analysis as described in “Materials and Methods.” The table shows the percentage of G1, S phase, and G2-M populations of cells under each treatment condition. These data are representative of at least three independently repeated experiments.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Effect of resveratrol on the nuclear cell cycle regulatory proteins in LNCaP cells. Exponentially growing LNCaP cells were treated with the indicated concentrations of resveratrol for 24 h. Nuclear lysates were prepared and immunoblot analysis using monoclonal antibodies to detect p21Cip1, p27Kip1, Cdk2, and cyclins A, B, and E was performed as described in “Materials and Methods.” Profiles of cell cycle regulatory proteins are representative of at least three independently repeated experiments.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Effect of resveratrol on Cdk2 activity associated with cyclin A and cyclin E in LNCaP cells. Exponentially growing LNCaP cells were treated with 10 or 25 μm resveratrol. Cyclin A- and cyclin E-specific immunoprecipitates were prepared from nuclear lysates, and Cdk2 activity was measured by histone H1 kinase assay (A), and p21Cip1, p27Kip1, cyclin A, and cyclin E were measured by Western blot analysis (B) in each of the immunoprecipitates as described in “Materials and Methods.” Immunoprecipitates recovered from equal amount of protein (25 μg) in individual nuclear lysates were used in these assays. Results are representative of at least two independently repeated experiments.

PreviousNext
Back to top
Cancer Research: 62 (9)
May 2002
Volume 62, Issue 9
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis
Nafisa Kuwajerwala, Eugenia Cifuentes, Subhash Gautam, Mani Menon, Evelyn R. Barrack and G. Prem Veer Reddy
Cancer Res May 1 2002 (62) (9) 2488-2492;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis
Nafisa Kuwajerwala, Eugenia Cifuentes, Subhash Gautam, Mani Menon, Evelyn R. Barrack and G. Prem Veer Reddy
Cancer Res May 1 2002 (62) (9) 2488-2492;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
  • Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy
Show more Advances in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement